Related Articles
Abnormal metabolic processes involved in the pathogenesis of non‑alcoholic fatty liver disease (Review)
Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease
Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)
Role of Ca<sup>2+</sup> channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review)